PP
ARAV

PDT Partners’s Aravive, Inc. Common Stock ARAV Stock Holding History

PDT Partners’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,570
Closed -$407K – 1165
2014
Q3 		$407K Buy
3,570
+1,622
+83% +$215K 0.01% 1005
2014
Q2 		$328K Buy
+1,948
New +$336K 0.01% 1168

Other funds holding ARAV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PDT Partners's ARAV Position: Q4 2014 in Review

PDT Partners sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2014, closing a stake of 3,570 shares — an estimated $407K sold.

PDT Partners first reported a position in ARAV in Q2 2014 and held it in 2 quarters. The position peaked at $407K in Q3 2014. 56 funds tracked by Wall St. Rank hold ARAV as of Q4 2014.

  • PDT Partners reported no remaining Aravive, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • PDT Partners sold 3,570 Aravive, Inc. Common Stock shares in Q4 2014, an estimated $407K.
  • PDT Partners first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • PDT Partners's Aravive, Inc. Common Stock position peaked at $407K in Q3 2014.
  • 56 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2014.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.